These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 39434155)
21. Long-Term Outcomes of Olfactory Neuroblastoma: MD Anderson Cancer Center Experience and Review of the Literature. Abdelmeguid AS; Bell D; Roberts D; Ferrarotto R; Phan J; Su SY; Kupferman M; Raza S; DeMonte F; Hanna E Laryngoscope; 2022 Feb; 132(2):290-297. PubMed ID: 34272876 [TBL] [Abstract][Full Text] [Related]
22. Esthesioneuroblastoma--what is the optimal treatment? Eriksen JG; Bastholt L; Krogdahl AS; Hansen O; Joergensen KE Acta Oncol; 2000; 39(2):231-5. PubMed ID: 10859017 [TBL] [Abstract][Full Text] [Related]
23. Pattern of loco-regional relapses and treatment in pediatric esthesioneuroblastoma: The French very rare tumors group (Fracture) contribution. Dumont B; Fresneau B; Claude L; Defachelles AS; Couloigner V; Puget S; Brisse HJ; Fréneaux P; Lacour B; Orbach D Pediatr Blood Cancer; 2020 Apr; 67(4):e28154. PubMed ID: 31930719 [TBL] [Abstract][Full Text] [Related]
24. Esthesioneuroblastoma: irradiation alone and surgery alone are not enough. Gruber G; Laedrach K; Baumert B; Caversaccio M; Raveh J; Greiner R Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):486-91. PubMed ID: 12243826 [TBL] [Abstract][Full Text] [Related]
25. Optimization of long-term outcomes for patients with esthesioneuroblastoma. Ow TJ; Hanna EY; Roberts DB; Levine NB; El-Naggar AK; Rosenthal DI; DeMonte F; Kupferman ME Head Neck; 2014 Apr; 36(4):524-30. PubMed ID: 23780581 [TBL] [Abstract][Full Text] [Related]
26. [Long-term experiences in the therapy of esthesioneuroblastoma]. Koch M; Constantinidis J; Dimmler A; Strauss C; Iro H Laryngorhinootologie; 2006 Oct; 85(10):723-30. PubMed ID: 16673299 [TBL] [Abstract][Full Text] [Related]
27. [Clinical analysis of 53 cases of esthesioneuroblastoma]. Chen YF; Yang AK; Zhang Q; Ouyang D; Chen WK; Chen FJ Ai Zheng; 2009 Mar; 28(3):308-11. PubMed ID: 19619448 [TBL] [Abstract][Full Text] [Related]
28. Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation. Monroe AT; Hinerman RW; Amdur RJ; Morris CG; Mendenhall WM Head Neck; 2003 Jul; 25(7):529-34. PubMed ID: 12808655 [TBL] [Abstract][Full Text] [Related]
29. Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors. Jethanamest D; Morris LG; Sikora AG; Kutler DI Arch Otolaryngol Head Neck Surg; 2007 Mar; 133(3):276-80. PubMed ID: 17372086 [TBL] [Abstract][Full Text] [Related]
30. Radiotherapy alone for local tumour control in esthesioneuroblastoma. Benfari G; Fusconi M; Ciofalo A; Gallo A; Altissimi G; Celani T; De Vincentiis M Acta Otorhinolaryngol Ital; 2008 Dec; 28(6):292-7. PubMed ID: 19205593 [TBL] [Abstract][Full Text] [Related]
31. Neck recurrence and mortality in esthesioneuroblastoma: Implications for management of the N0 neck. Naples JG; Spiro J; Tessema B; Kuwada C; Kuo CL; Brown SM Laryngoscope; 2016 Jun; 126(6):1373-9. PubMed ID: 26607219 [TBL] [Abstract][Full Text] [Related]
33. Utility of adjuvant chemotherapy in patients receiving surgery and adjuvant radiotherapy for primary treatment of esthesioneuroblastoma. Miller KC; Marinelli JP; Van Gompel JJ; Link MJ; Janus JR; Foote RL; Price KA; Garcia J; Rivera M; Chintakuntlawar AV Head Neck; 2019 May; 41(5):1335-1341. PubMed ID: 30536472 [TBL] [Abstract][Full Text] [Related]
34. Survival Analysis and Prognostic Factors After Endonasal Resection of Advanced Olfactory Neuroblastomas: A Single Institution Experience. Song X; Yang J; Yuan C; Gu D; Wang L; Zhang Q; Zhou C; Wang H; Hu L; Zhang C; Liu Q; Wang D; Sun X; Yu H J Otolaryngol Head Neck Surg; 2024; 53():19160216241267737. PubMed ID: 39164943 [TBL] [Abstract][Full Text] [Related]
35. Absence of Survival Improvement for Patients with Esthesioneuroblastoma Over the Past 2 Decades: A Population-Based Study. Vuong HG; Nguyen DD; El-Rassi E; Ngo TNM; Dunn IF World Neurosurg; 2022 Jan; 157():e245-e253. PubMed ID: 34628034 [TBL] [Abstract][Full Text] [Related]
36. Optimal treatment and prognostic factors for esthesioneuroblastoma: retrospective analysis of 187 Chinese patients. Xiong L; Zeng XL; Guo CK; Liu AW; Huang L BMC Cancer; 2017 Apr; 17(1):254. PubMed ID: 28399835 [TBL] [Abstract][Full Text] [Related]
37. Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma. Eich HT; Hero B; Staar S; Micke O; Seegenschmiedt H; Mattke A; Berthold F; Müller RP Strahlenther Onkol; 2003 Apr; 179(4):233-40. PubMed ID: 12707712 [TBL] [Abstract][Full Text] [Related]
38. Comparison of Open and Endoscopic Approaches in the Resection of Esthesioneuroblastoma. Barinsky GL; Azmy MC; Kilic S; Grube JG; Baredes S; Hsueh WD; Eloy JA Ann Otol Rhinol Laryngol; 2021 Feb; 130(2):136-141. PubMed ID: 32627574 [TBL] [Abstract][Full Text] [Related]